245 related articles for article (PubMed ID: 12903501)
1. [High dose intravenous immunoglobulins in treating systemic lupus erythematosus-associated thrombocytopenia].
Zhang X; Dong Y; Tang F; Zhang F; Li H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):82-4. PubMed ID: 12903501
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
Arnal C; Piette JC; Léone J; Taillan B; Hachulla E; Roudot-Thoraval F; Papo T; Schaeffer A; Bierling P; Godeau B
J Rheumatol; 2002 Jan; 29(1):75-83. PubMed ID: 11824975
[TBL] [Abstract][Full Text] [Related]
3. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
Pirner K; Rubbert A; Burmester GR; Kalden JR; Manger B
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
[TBL] [Abstract][Full Text] [Related]
5. A case report of the efficacy of apheresis for refractory autoimmune thrombocytopenia in a patient with systemic lupus erythematosus associated hemolytic anemia.
Yamaji K; Tsuda H; Hashimoto H
Ther Apher Dial; 2004 Jun; 8(3):227-31. PubMed ID: 15154876
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
Toubi E; Kessel A; Shoenfeld Y
Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
[TBL] [Abstract][Full Text] [Related]
7. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
Berkowitz RL; Lesser ML; McFarland JG; Wissert M; Primiani A; Hung C; Bussel JB
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):249-55. PubMed ID: 17666597
[TBL] [Abstract][Full Text] [Related]
8. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
[TBL] [Abstract][Full Text] [Related]
9. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.
Kuwana M; Kaburaki J; Okazaki Y; Miyazaki H; Ikeda Y
Rheumatology (Oxford); 2006 Jul; 45(7):851-4. PubMed ID: 16418192
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins.
Akashi K; Nagasawa K; Mayumi T; Yokota E; Oochi N; Kusaba T
J Rheumatol; 1990 Mar; 17(3):375-9. PubMed ID: 2332861
[TBL] [Abstract][Full Text] [Related]
12. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
[TBL] [Abstract][Full Text] [Related]
13. SLE-associated thrombocytopenia in pregnancy: successful outcome with combined IgG infusion and platelet transfusion.
Li EK; Li CY; Cohen MG
Br J Clin Pract; 1993; 47(6):338-9. PubMed ID: 8117561
[TBL] [Abstract][Full Text] [Related]
14. Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus.
Lurie DP; Kahaleh MB
J Rheumatol; 1982; 9(2):311-4. PubMed ID: 7115559
[TBL] [Abstract][Full Text] [Related]
15. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison.
Scaradavou A; Cunningham-Rundles S; Ho JL; Folman C; Doo H; Bussel JB
Am J Hematol; 2007 May; 82(5):335-41. PubMed ID: 17154377
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
Sherer Y; Shoenfeld Y
Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
[TBL] [Abstract][Full Text] [Related]
17. High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.
Schroeder JO; Zeuner RA; Euler HH; Löffler H
J Rheumatol; 1996 Jan; 23(1):71-5. PubMed ID: 8838511
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
Bayry J; Lacroix-Desmazes S; Delignat S; Mouthon L; Weill B; Kazatchkine MD; Kaveri SV
Arthritis Rheum; 2003 Dec; 48(12):3497-502. PubMed ID: 14674000
[TBL] [Abstract][Full Text] [Related]
19. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.
Nieto-Aristizábal I; Martínez T; Urbano MA; Posso-Osorio I; Plata IF; Garcia-Robledo JE; Aragón CC; Santos VA; Tobón GJ
Lupus; 2019 Nov; 28(13):1566-1570. PubMed ID: 31653191
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease.
Becker BN; Fuchs H; Hakim R
J Am Soc Nephrol; 1995 Apr; 5(10):1746-50. PubMed ID: 7787141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
